Compare AbCellera Biologics Inc (ABCL) vs Cognizant Technology Solutions Corp (CTSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Cognizant Technology Solutions Corp — how do they compare? AbCellera Biologics Inc trades at $9.22 (market cap $2.99B), while Cognizant Technology Solutions Corp trades at $57.8 (market cap $26.40B). The key difference: Cognizant Technology Solutions Corp is far larger — about 8.8× AbCellera Biologics Inc's market cap, and Cognizant Technology Solutions Corp pays a 2.25% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | CTSH | |
|---|---|---|
Market Cap | $2.99B | $26.40B |
Sector | Health | Technology |
52-Week High | $9.76 | $86.70 |
52-Week Low | $2.78 | $38.73 |
Enterprise Value | $2.58B | $27.44B |
Dividend Yield | — | 2.25% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Cognizant Technology Solutions Corp
Cognizant is a global IT services provider, offering consulting and outsourcing services to some of the world's largest enterprises spanning the financial services, media and communications, healthcare, natural resources, and consumer products industries. Cognizant employs nearly 300,000 people globally, roughly 70% of whom are in India, although the company's headquarters are in Teaneck, New Jersey.
Read more on CTSH →
